Trends in viral load and CD4 cell count monitoring among adults with HIV in the Asia-Pacific region: A multicentre observational cohort study of the TREAT Asia HIV Observational Database, 2003–2018
Year: 2026
Type: article
Abstract: INTRODUCTION: Viral load (VL) testing is recommended for monitoring antiretroviral therapy (ART), whereas CD4 testing is increasingly targeted. Changes in these practices across Asia-Pacific remain unclear. We examined trends in VL and CD4 testing rates and their associations with AIDS diagnosis and mortality. METHODS: We analysed multicentre cohort data from adults receiving ART during 2003-2018 using Poisson and Fine-Gray competing-risk regression. RESULTS: Among 8,446 patients, VL testing rates remained steady at one test per person-year during 2003-2018. Increased VL testing was associated with more frequent CD4 testing (>2 tests in the previous year; incidence rate ratio (IRR)=1.57, 95%CI 1.53-1.60), later follow-up years (2008-2012: IRR = 1.15, 95%CI 1.12-1.18; 2013-2015: IRR = 1.07, 95%CI 1.04-1.10), older age (31-40years: IRR = 1.06, 95%CI 1.03-1.08; 41-50years: IRR = 1.08, 95%CI 1.05-1.11; > 50years: IRR = 1.07, 95%CI 1.03-1.11), higher current VL (401-1000 copies/mL: IRR = 1.16, 95%CI 1.09-1.24; > 1000 copies/mL: IRR = 1.07, 95%CI 1.04-1.11), initial ART regimen (nucleoside/nucleotide reverse transcriptase inhibitor plus protease inhibitor (NRTI+PI): IRR = 1.07, 95%CI 1.04-1.10; other combinations: IRR = 1.11, 95%CI 1.05-1.17), and higher country income levels (upper-middle: IRR = 2.17, 95%CI 2.11-2.23; high: IRR = 3.14, 95%CI 3.03-3.26). CD4 testing rates decreased from 2.04 to 1.06 tests per person-year over the same period. Lower CD4 testing rate was associated with HIV exposure mode (men who have sex with men (MSM): IRR = 0.94, 95%CI 0.92-0.96; injecting drug use (IDU): IRR = 0.93, 95%CI 0.90-0.97; other/unknown: IRR = 0.90, 95%CI 0.87-0.93), higher current CD4 (201-350 cells/µL: IRR = 0.95, 95%CI 0.93-0.97; 351-500 cells/µL: IRR = 0.89, 95%CI 0.87-0.91; > 500 cells/µL: IRR = 0.85, 95%CI 0.83-0.87) and receiving an NRTI+PI first-line combination (IRR = 0.96, 95% CI 0.94-0.98). VL and CD4 testing rates were not significantly associated with AIDS diagnosis. However, having >2 CD4 tests in the previous year was associated with higher mortality risk. CONCLUSION: VL testing was broadly consistent with annual monitoring, although individual gaps may remain. Differentiated strategies should maintain annual VL testing and targeted CD4 testing for advanced HIV disease.
Source: PLoS ONE
Authors: Mark Kristoffer Ungos Pasayan, Awachana Jiamsakul, Evy Yunihastuti, Iskandar Azwa, Jun Yong Choi, Nagalingeswaran Kumarasamy, Anchalee Avihingsanon, Romanee Chaiwarith, Yu-Jiun Chan, Vohith Khol, Sasisopin Kiertiburanakul, Man Po Lee, I. Ketut Agus Somia, Sanjay Pujari, Cuong Duy Do, Thach Ngoc Pham, Fujie Zhang, Suwimon Khusuwan, Oon Tek Ng, Junko Tanuma, Yasmin Gani, Rohidas Borse, Jeremy Ross, Rossana Ditangco, on behalf of IeDEA Asia-Pacific
Institutions: Research Institute for Tropical Medicine, UNSW Sydney, Kirby Institute, University of Indonesia, Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo, University of Malaya, Yonsei University, Voluntary Health Services Hospital, Thai Red Cross Society, HIV Netherlands Australia Thailand Research Collaboration, Chiang Mai University, Taipei Veterans General Hospital, National Center for HIV/AIDS, Dermatology and STD, Mahidol University, Queen Elizabeth Hospital, Udayana University, Bạch Mai Hospital, Hospital for Tropical Diseases, Capital Medical University, Beijing Ditan Hospital, ChiangRai Prachanukroh Hospital, Tan Tock Seng Hospital, National Centre for Infectious Diseases, National Center for Global Health and Medicine, Hospital Sungai Buloh, B. J. Medical College & Sassoon Hospital, American Foundation for AIDS Research
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,382
Funders: Department of Bioethics, amfAR, The Foundation for AIDS Research, National Center for Global Health and Medicine, Australian Government, Universitas Udayana, University of New South Wales, Yonsei University, Capital Medical University, Chiang Mai University, Mahidol University, Universiti Malaya, Taipei Veterans General Hospital, National Institutes of Health, Yonsei University College of Medicine, Fakultas Kedokteran, Universitas Indonesia, National Heart, Lung, and Blood Institute, National Institute of Mental Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, Fogarty International Center, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development
OpenAlex ID: W7140142585
